151 related articles for article (PubMed ID: 22387393)
1. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.
Qian YW; Chen Y; Yang W; Fu J; Cao J; Ren YB; Zhu JJ; Su B; Luo T; Zhao XF; Dai RY; Li JJ; Sun W; Wu MC; Feng GS; Wang HY
Gastroenterology; 2012 Jun; 142(7):1547-58.e14. PubMed ID: 22387393
[TBL] [Abstract][Full Text] [Related]
2. OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
Yang W; Wang C; Lin Y; Liu Q; Yu LX; Tang L; Yan HX; Fu J; Chen Y; Zhang HL; Tang L; Zheng LY; He YQ; Li YQ; Wu FQ; Zou SS; Li Z; Wu MC; Feng GS; Wang HY
J Hepatol; 2012 Sep; 57(3):613-20. PubMed ID: 22612999
[TBL] [Abstract][Full Text] [Related]
3. The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling.
Dong LW; Yang GZ; Pan YF; Chen Y; Tan YX; Dai RY; Ren YB; Fu J; Wang HY
Cell Res; 2011 Aug; 21(8):1248-61. PubMed ID: 21691299
[TBL] [Abstract][Full Text] [Related]
4. p28GANK inhibits endoplasmic reticulum stress-induced cell death via enhancement of the endoplasmic reticulum adaptive capacity.
Dai RY; Chen Y; Fu J; Dong LW; Ren YB; Yang GZ; Qian YW; Cao J; Tang SH; Yang SL; Wang HY
Cell Res; 2009 Nov; 19(11):1243-57. PubMed ID: 19736567
[TBL] [Abstract][Full Text] [Related]
5. p28(GANK) associates with p300 to attenuate the acetylation of RelA.
Ren YB; Luo T; Li J; Fu J; Wang Q; Cao GW; Chen Y; Wang HY
Mol Carcinog; 2015 Dec; 54(12):1626-35. PubMed ID: 25400040
[TBL] [Abstract][Full Text] [Related]
6. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
[TBL] [Abstract][Full Text] [Related]
7. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways.
Fu J; Chen Y; Cao J; Luo T; Qian YW; Yang W; Ren YB; Su B; Cao GW; Yang Y; Yan YQ; Shen F; Wu MC; Feng GS; Wang HY
Hepatology; 2011 Jan; 53(1):181-92. PubMed ID: 21254169
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
9. Self-renewal of tumor-initiating cells: what's new about hepatocellular carcinoma?
Alisi A; Baffet G
Gastroenterology; 2012 Jun; 142(7):1414-6. PubMed ID: 22542831
[No Abstract] [Full Text] [Related]
10. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
Fu X; Tan L; Liu S; Li H; Chen L; Qin J; Wu M; Wang H
J Cancer Res Clin Oncol; 2004 Sep; 130(9):514-20. PubMed ID: 15221469
[TBL] [Abstract][Full Text] [Related]
11. Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export.
Chen Y; Li HH; Fu J; Wang XF; Ren YB; Dong LW; Tang SH; Liu SQ; Wu MC; Wang HY
Cell Res; 2007 Dec; 17(12):1020-9. PubMed ID: 18040287
[TBL] [Abstract][Full Text] [Related]
12. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.
Li L; Tang J; Zhang B; Yang W; LiuGao M; Wang R; Tan Y; Fan J; Chang Y; Fu J; Jiang F; Chen C; Yang Y; Gu J; Wu D; Guo L; Cao D; Li H; Cao G; Wu M; Zhang MQ; Chen L; Wang H
Gut; 2015 Jan; 64(1):156-67. PubMed ID: 24572141
[TBL] [Abstract][Full Text] [Related]
14. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.
Muramatsu S; Tanaka S; Mogushi K; Adikrisna R; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Nakayama K; Tanaka H; Yamaoka S; Arii S
Hepatology; 2013 Jul; 58(1):218-28. PubMed ID: 23447025
[TBL] [Abstract][Full Text] [Related]
15. Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma.
Wu G; Wilson G; Zhou G; Hebbard L; George J; Qiao L
Discov Med; 2015 Oct; 20(110):219-29. PubMed ID: 26562475
[TBL] [Abstract][Full Text] [Related]
16. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.
Murakami S; Ninomiya W; Sakamoto E; Shibata T; Akiyama H; Tashiro F
Stem Cells; 2015 Sep; 33(9):2652-63. PubMed ID: 26013162
[TBL] [Abstract][Full Text] [Related]
17. Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation.
D'Souza AM; Jiang Y; Cast A; Valanejad L; Wright M; Lewis K; Kumbaji M; Shah S; Smithrud D; Karns R; Shin S; Timchenko N
Cell Mol Gastroenterol Hepatol; 2018; 6(3):239-255. PubMed ID: 30109252
[TBL] [Abstract][Full Text] [Related]
18. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma.
Tan L; Fu XY; Liu SQ; Li HH; Hong Y; Wu MC; Wang HY
Liver Int; 2005 Jun; 25(3):667-76. PubMed ID: 15910504
[TBL] [Abstract][Full Text] [Related]
19. ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells.
Zhu P; Wang Y; He L; Huang G; Du Y; Zhang G; Yan X; Xia P; Ye B; Wang S; Hao L; Wu J; Fan Z
J Clin Invest; 2015 Oct; 125(10):3795-808. PubMed ID: 26426078
[TBL] [Abstract][Full Text] [Related]
20. FXR-Gankyrin axis is involved in development of pediatric liver cancer.
Valanejad L; Lewis K; Wright M; Jiang Y; D'Souza A; Karns R; Sheridan R; Gupta A; Bove K; Witte D; Geller J; Tiao G; Nelson DL; Timchenko L; Timchenko N
Carcinogenesis; 2017 Jul; 38(7):738-747. PubMed ID: 28535186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
